150 related articles for article (PubMed ID: 32715348)
1. Clinical impact of preoperative serum p53 antibody titers in 1487 patients with surgically treated esophageal squamous cell carcinoma: a multi-institutional study.
Takashi S; Satoshi Y; Akihiko O; Naoya Y; Yusuke T; Kentaro M; Yu O; Yasuaki N; Koichi Y; Takashi F; Ryo O; Isamu H; Chikara K; Kosuke N; Yasuhiro T; Kazuhiko Y; Hideaki S
Esophagus; 2021 Jan; 18(1):65-71. PubMed ID: 32715348
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of high serum p53 antibody titers in patients with esophageal squamous cell carcinoma.
Suzuki T; Yajima S; Ishioka N; Nanami T; Oshima Y; Washizawa N; Funahashi K; Otsuka S; Nemoto T; Shimada H
Esophagus; 2018 Oct; 15(4):294-300. PubMed ID: 29959634
[TBL] [Abstract][Full Text] [Related]
3. Peritherapeutic Serum p53 Antibody Titers are Predictors of Survival in Patients with Esophageal Squamous Cell Carcinoma Undergoing Neoadjuvant Chemotherapy and Surgery.
Yamashita K; Makino T; Tanaka K; Yamasaki M; Yamamoto M; Miyazaki Y; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Mori M; Doki Y
World J Surg; 2017 Jun; 41(6):1566-1574. PubMed ID: 28108772
[TBL] [Abstract][Full Text] [Related]
4. Five-year postsurgical monitoring of serum p53 antibody for locally advanced esophageal squamous cell carcinoma.
Kochi R; Yajima S; Nanami T; Suzuki T; Oshima Y; Tokura N; Takatsuka J; Funahashi K; Tochigi N; Shimada H
Clin J Gastroenterol; 2018 Aug; 11(4):278-281. PubMed ID: 29497977
[TBL] [Abstract][Full Text] [Related]
5. Perioperative changes of serum p53 antibody titer is a predictor for survival in patients with esophageal squamous cell carcinoma.
Shimada H; Shiratori T; Takeda A; Matsushita K; Okazumi S; Akutsu Y; Matsubara H; Nomura F; Ochiai T
World J Surg; 2009 Feb; 33(2):272-7. PubMed ID: 19052812
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of perioperative change in serum p53 antibody titers in esophageal squamous cell carcinoma.
Haneda R; Mayanagi S; Inoue M; Ishii K; Morita Y; Kikuchi H; Hiramatsu Y; Takeuchi H; Tsubosa Y
Esophagus; 2023 Oct; 20(4):669-678. PubMed ID: 37212971
[TBL] [Abstract][Full Text] [Related]
7. The effectiveness of serum midkine in detecting esophageal squamous cell carcinoma.
Shiratori F; Ito M; Yajima S; Suzuki T; Oshima Y; Nanami T; Funahashi K; Shimada H
Esophagus; 2019 Jul; 16(3):246-251. PubMed ID: 30778774
[TBL] [Abstract][Full Text] [Related]
8. Low anti-CFL1 antibody with high anti-ACTB antibody is a poor prognostic factor in esophageal squamous cell carcinoma.
Ito M; Hiwasa T; Yajima S; Suzuki T; Oshima Y; Nanami T; Sumazaki M; Shiratori F; Li SY; Iwadate Y; Sugimoto K; Mori M; Kuwabara S; Takizawa H; Shimada H
Esophagus; 2022 Oct; 19(4):617-625. PubMed ID: 35780443
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of carcinoembryonic antigen in 1822 surgically treated esophageal squamous cell carcinoma: multi-institutional study of the Japan Esophageal Society.
Suzuki T; Yajima S; Okamura A; Yoshida N; Taniyama Y; Murakami K; Ohkura Y; Nakajima Y; Yagi K; Fukuda T; Ogawa R; Hoshino I; Kunisaki C; Narumiya K; Tsubosa Y; Yamada K; Shimada H;
Dis Esophagus; 2022 Dec; 35(12):. PubMed ID: 35661884
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Impact of Pretreatment Serum CYFRA Status in 1047 Patients with Esophageal Squamous Cell Carcinoma Who Underwent Radical Resection: A Japan Esophageal Society Promotion Research.
Ishioka N; Suzuki T; Yajima S; Murakami K; Ohkura Y; Fukuda T; Yagi K; Okamura A; Hoshino I; Kunisaki C; Nakajima Y; Narumiya K; Ogawa R; Shimada H
Ann Thorac Cardiovasc Surg; 2022 Jun; 28(3):163-170. PubMed ID: 34690219
[TBL] [Abstract][Full Text] [Related]
11. Serum p53 antibody: useful for detecting gastric cancer but not for predicting prognosis after surgery.
Oshima Y; Suzuki T; Yajima S; Nanami T; Shiratori F; Funahashi K; Shimada H
Surg Today; 2020 Nov; 50(11):1402-1408. PubMed ID: 32458231
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of serum p53 antibody in patients with esophageal squamous cell carcinoma.
Shimada H; Nabeya Y; Okazumi S; Matsubara H; Funami Y; Shiratori T; Hayashi H; Takeda A; Ochiai T
Surgery; 2002 Jul; 132(1):41-7. PubMed ID: 12110794
[TBL] [Abstract][Full Text] [Related]
13. Preoperative squamous cell carcinoma antigen and albumin serum levels predict the survival of patients with stage T1-3N0M0 esophageal squamous cell carcinoma: a retrospective observational study.
Wu LL; Liu X; Huang W; Lin P; Long H; Zhang LJ; Ma GW
J Cardiothorac Surg; 2020 May; 15(1):115. PubMed ID: 32456707
[TBL] [Abstract][Full Text] [Related]
14. Preoperative serum C-reactive protein levels and postoperative survival in patients with esophageal squamous cell carcinoma: a propensity score matching analysis.
Huang W; Wu L; Liu X; Long H; Rong T; Ma G
J Cardiothorac Surg; 2019 Sep; 14(1):167. PubMed ID: 31533862
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of anti-p53 and anti-KRas circulating antibodies in esophageal cancer patients treated with chemoradiotherapy.
Blanchard P; Quero L; Pacault V; Schlageter MH; Baruch-Hennequin V; Hennequin C
BMC Cancer; 2012 Mar; 12():119. PubMed ID: 22448886
[TBL] [Abstract][Full Text] [Related]
16. Serum p53 antibody as a predictor of early recurrence in patients with postoperative esophageal squamous cell carcinoma.
Takahashi K; Miyashita M; Nomura T; Makino H; Futami R; Kashiwabara M; Katsuta M; Tajiri T
Dis Esophagus; 2007; 20(2):117-22. PubMed ID: 17439594
[TBL] [Abstract][Full Text] [Related]
17. The combination of positive anti‑WDR1 antibodies with negative anti‑CFL1 antibodies in serum is a poor prognostic factor for patients with esophageal carcinoma.
Ito M; Yajima S; Suzuki T; Oshima Y; Nanami T; Sumazaki M; Shiratori F; Wang H; Hu L; Takizawa H; Li SY; Iwadate Y; Hiwasa T; Shimada H
Med Int (Lond); 2023; 3(2):11. PubMed ID: 36875818
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of preoperative serum tumor markers in esophageal squamous cell carcinoma.
Zhao H; Chen W; Wu J; Wang L; Mao W
J Cancer Res Ther; 2014 Nov; 10 Suppl():C179-85. PubMed ID: 25450279
[TBL] [Abstract][Full Text] [Related]
19. The value of complete blood count for the prognosis analysis of preoperative esophageal squamous cell carcinoma.
Lv X; Han S; Xu B; Deng Y; Feng Y
BMC Cancer; 2021 Sep; 21(1):1072. PubMed ID: 34592957
[TBL] [Abstract][Full Text] [Related]
20. Circulating p53 antibodies, p53 gene mutational profile and product accumulation in esophageal squamous-cell carcinoma in India.
Ralhan R; Arora S; Chattopadhyay TK; Shukla NK; Mathur M
Int J Cancer; 2000 Mar; 85(6):791-5. PubMed ID: 10709097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
